Macrophages and HIV-1-associated dementia

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 4, 2000, Pages 273-279

  Boven, Leonie A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

HIV associated dementia; Macrophages

Indexed keywords

NEUROTOXIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTROCYTE; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; REVIEW;

AIDS DEMENTIA COMPLEX; ASTROCYTES; BLOOD-BRAIN BARRIER; HIV-1; HUMANS; MACROPHAGES; NEURODEGENERATIVE DISEASES; NEUROTOXINS; RETROVIRIDAE PROTEINS;

EID: 0034566816     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. ADAMSON D. C., KOPNISKY K. L., DAWSON T. M. and DAWSON V. L. (1999): Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J. Neurosci., 19, 64-71.
2. ADAMSON D. C., MCARTHUR J. C., DAWSON T. M. and DAWSON V. L. (1999): Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol. Med., 5, 98-109.
3. ADAMSON D. C., WILDEMANN B., SASAKI M., GLASS J. D., MC ARTHUR J. C., CHRISTOV V. I., DAWSON T. M. and DAWSON V. L. (1996): Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science, 274, 1917-1921.
4. ALBINI A., BENELLI R., GIUNCIUGLIO D., CAI T., MARIANI G., FERRINI S. and NOONAN D. M. (1998): Identification of a novel domain of HIV tat involved in monocyte chemotaxis. J. Biol. Chem., 273, 15895-15900.
5. ALBINI A., FERRINI S., BENELLI R., SFORZINI S., GIUNCIUGLIO D., ALUIGI M. G., PROUDFOOT A. E., ALOUANI S., WELLS T. N., MARIANI G., RABIN R. L., FARBER J. M. and NOONAN D. M. (1998): HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA, 95, 13153-13158.
6. BAGGIOLINI M., DEWALD B. and MOSER B. (1997): Human chemokines: an update. Annu. Rev. Immunol., 15, 675-705.
7. BORING L., GOSLING J., CHENSUE S. W., KUNKEL S. L., FARESE R. V. JR., BROXMEYER H. E. and CHARO I. F. (1997): Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest., 100, 2552-2561.
8. BOVEN L. A., MIDDEL J., PORTEGIES P., VERHOEF J., JANSEN G. H. and NOTTET H. S. L. M. (1999): Overexpression of nerve growth factor and basis fibroblast growth factor in AIDS dementia complex. J. Neuroimmunol., 97, 154-162.
9. BOVEN L. A., GOMES L., HERY C., GRAY F., VERHOEF J., PORTEGIES P., TARDIEU M. and NOTTET H. S. L. M. (1999): Increased peroxynitrite activity in AIDS dementia complex. Implications for the neuropathogenesis of HIV-1 infection. J. Immunol., 162, 4319-4327.
10. BRACK-WERNER R. (1999): Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS, 13, 1-22.
11. CAIRNS J. S. and D'SOUZA M. P. (1998): Chemokines and HIV-1 second receptors: the therapeutic connection. Nat. Med., 4, 563-568.
12. CHEN P., MAYNE M., POWER C. and NATH A. (1997): The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem., 272, 22385-22388.
13. CHONG Y. H., SEOH J. Y. and PARK H. K. (1998): Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides. J. Mol. Neurosci., 10, 129-141.
14. COLASANTI M., DI PUCCHIO T., PERSICHINI T., SOGOS V., PRESTA M. and LAURO G. M. (1995): Inhibition of inducible nitrix oxide synthase mRNA expression by basic fibroblast growth factor in human microglial cells. Neurosci. Lett., 195, 45-48.
15. CONANT K., GARZINO-DEMO A., NATH A., MCARTHUR J. C., HALLIDAY W., POWER C., GALLO R. C. and MAJOR E. O. (1998): Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA, 95, 3117-3121.
16. CONANT K., MCARTHUR J. C., GRIFFIN D. E., SJULSON L., WAHL L. M. and IRANI D. N. (1999): Cerebrospinal fluid levels of MMP-2, 7, 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol., 46, 391-398.
17. DEL SORBO L., DE MARTINO A., BIANCONE L., BUSSOLATI B., CONALDI P. G., TONIOLO A. and CAMUSSI G. (1999): The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 tat. Eur. J. Immunol., 29, 1513-1521.
18. DHAWAN S., PURI R. K., KUMAR A., DUPLAN H., MASSON J. M. and AGGARWAL B. B. (1997): Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood, 90, 1535-1544.
19. DHAWAN S., TORO L. A., JONES B. E. and MELTZER M. S. (1992): Interactions between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukoc. Biol., 52, 244-248.
20. DHAWAN S., WEEKS B. S., SODERLAND C., SCHNAPER H. W., TORO L. A., ASTHANA S. P., HEWLETT I. K., STETLER STEVENSON W. G., YAMADA S. S., YAMADA K. M. and MELTZER M. S. (1995): HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J. Immunol., 154, 422-432.
21. DICKSON D. W., MATTIACE L. A., KURE K., HUTCHINS K., LYMAN W. D. and BROSNAN C. F. (1991): Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest., 64, 135-156.
22. DIOP A. G., LESORT M., ESCLAIRE F., SINDOU P., COURATIER P. and HUGON J. (1994): Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett., 165, 187-190.
23. FURIE M. B. and RANDOLPH G. J. (1995): Chemokines and tissue injury. Am. J. Pathol., 146, 1287-1301.
24. GELBARD H. A., NOTTET H. S., SWINDELLS S., JETT M., DZENKO K. A., GENIS P., WHITE R., WANG L., CHOI Y. B., ZHANG D. et al. (1994): Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol., 68, 4628-4635.
25. GESSANI S., BORGHI P., FANTUZZI L., VARANO B., CONTI L., PUDDU P. and BELARDELLI F. (1997): Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation. J. Leukoc. Biol., 62, 49-53.
26. GIULIAN D., VACA K. and NOONAN C. A. (1990): Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science, 250, 1593-1596.
27. GIULIAN D., WENDT E., VACA and NOONAN C. A. (1993): The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA, 90, 2769-2773.
28. GIULIAN D., YU J., LI X., TOM D., LI J., WENDT E., LIN S. N., SCHWARCZ R. and NOONAN C. (1996): Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci, 16, 3139-3153.
29. GLASS J. D., FEDOR H., WESSELINGH S. L. and MCARTHUR J. C. (1995): Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol., 38, 755-762.
30. GOBBEL G. T., CHAN T. Y. and CHAN P. H. (1997): Nitric oxid- and superoxide-mediated toxecity in cerebral endothelial cells. J. Pharmacol. Exp. Ther., 282, 1600-1607.
31. GOEBELER M., YOSHIMURA T., TOKSOY A., RITIER U., BROCKER E. B. and GILLITZER R. (1997): The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J. Ivest. Dermatol., 108, 445-451.
32. GOLDSTEIN G. (1996): HIV-1 Tat protein as a potential AIDS vaccine. Nat. Med., 2, 960-964.
33. GOW A. J., DURAN D., MALCOLM S. and ISCHIROPOULOS H. (1996): Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett., 385, 63-66.
34. HORI K., BURD P. R., FURUKE K., KUTZA J., WEIH K A. and CLOUSE K. A. (1999): Human immunodeficiency virus-1-infected macrophages induce inducible nitrix oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficience syndrome. Blood, 93, 1843-1850.
35. IMAIZUMI S., KONDO T., DELI M. A., GOBBEL G., JOO F., EPSTEIN C. J., YOSHIMOTO T. and CHAN P. H. (1996): The influence of oxygen free radicals on the permeability of the monolayer of cultured brain endothelial cells. Neurochem. Int., 29, 205-211.
36. JONES K. A. (1993): Tat and the HIV-1 promotor. Curr. Opin. Cell Biol., 5, 461-468.
37. JONES K. A. and: PETERLIN B. M. (1994): Control of RNA initiation and elongation at the HIV-1 promotor. Annu. Rev. Biochem., 63, 717-743.
38. KAUL M. and LIPTON S. A. (1999): Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 96, 8212-8216.
39. KERR S. J., ARMATI P. J. and BREW B. J. (1995): Neurocytotoxity of quinolinic acid in human brain cultures. J. Neurovirol., 1, 375-380.
40. KERR S. J., ARMATI P. J., GUILLEMIN G. J. and BREW B. J. (1998): Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS, 12, 355-363.
41. KORT J. J. (1998): Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses, 14, 1329-1339.
42. KURE K., LYMAN W. D., WEIDENHEIM K. M. and DICKSON D. W. (1990): Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am. J. Pathol., 136, 1085-1092.
43. KURIHARA T., WARR G., LOY J. and BRAVO R. (1997): Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med., 186, 1757-1762.
44. LAFRENIE R. M., WAHL L. M., EPSTEIN J. S., HEWLETT I. K., YAMADA K. M. and DHAWAN S. (1996): HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J. Immunol., 156, 1638-1645.
45. LAFRENIE R. M., WAHL L. M., EPSTEIN J. S., HEWLETT I. K., YAMADA K. M. and DHAWAN S. (1996): HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol., 157, 974-977.
46. LANNUZEL A., BARNIER J. V., HERY C., HUYNH V. T., GUIBERT B., GRAY F., VINCENT J. D. and TARDIEU M. (1997): Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol., 42, 847-856.
47. LEE B. and MONTANER L. J. (1999): Chemokine immunobiology in HIV-1 pathogenesis. J. Leukoc. Biol., 65, 552-565.
48. LIU J., ZHAO M. L., BROSNAN C. F. and LEE S. C. (1996): Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. J. Immunol., 157, 3569-3576.
49. LUKACS N. W., STRIETER R. M., ELNER V., EVANOFF H. L., BURDICK M. D. and KUNKEL S. L. (1995): Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood, 86, 2767-2773.
50. MACLENNAN K. M., SMITH P. F. and DARLINGTON C. L. (1996): Platelet-activating factor in the CNS. Prog. Neurobiol., 50, 585-596.
51. MAGNUSON D. S., KNUDSEN B. E., GEIGER J. D., BROWNSTONE R. M. and NATH A. (1995): Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol., 37, 373-380.
52. MARK R. J., KELLER J. N., KRUMAN I. and MATTSON M. P. (1997): Basic FGF attenuates amyloid beta-peotide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons. Brain Res., 756, 205-214.
53. MASLIAH E., ACHIM C. L., GE N., DE TERESA R., TERRY R. D. and WILEY C. A. (1992): Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol., 32, 321-329.
54. MATTSON M. P., LOVELL M. A., FURUKAWA K. and MARKESBERY W. R. (1995): Neurotrophic factors attenuate glutamate - induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem., 65, 1740-1751.
55. MCMANUS C. M., BROSNAN C. F. and BERMAN J. W. (1998): Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia. J. Immunol, 160, 1449-1455.
56. MCPHEE D. A., GREENWAY A. L., HOLLOWAY G., SMITH K., DEACON N., PEMBERTON L. and BREW B. J. (1998): Anomalies in Nef expression within the central nervous system of HIV-1 postivive individuals/AIDS patients with or without AIDS dementia complex. J. Neurovirol, 4, 291-300.
57. MENGOZZI M., DE FILIPPI C., TRANSIDICO P., BISWAS P., COTA M., GHEZZI S., VICENZI E., MANTOVANI A., SOZZANI S. and POLI G. (1999): Human immunodeficiency viru replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood, 93, 1851-1857.
58. MOSER B., LOETSCHER M., PIALI L. and LOETSCHER P. (1998): Lymphocyte responses to chemokines. Int. Rev. Immunol., 16, 323-344.
59. NATH A., CONANT K., CHEN P., SCOTT C. and MAJOR E. O. (1999): Transient exposure to HIV-1 tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem., 274, 17098-17120.
60. NATH A., PSOOY K., MARTIN C., KNUDSEN B., MAGNUSON D. S., HAUGHEY N. and GEIGER J. D. (1996): Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol., 70, 1475-1480.
61. NAVIA B. A., JORDAN B. D. and PRICE R. W. (1986): The AIDS dementia complex. I. Clinical features. Ann. Neurol., 19, 517-524.
62. NEW D. R., MA M. H., EPSTEIN L. G., NATH A. and GELBARD H. A. (1997): Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol., 3, 168-173.
63. NOTTET H. S. L. M., BAR D. R., VAN HASSEL H., VERHOEF J. and BOVEN L. A. (1997): Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis. J. Leukoc. Biol., 62, 107-116.
64. NOTTET H. S. L. M., FLANAGAN E. M., FLANAGAN C. R., GELBARD H. A., GENDELMAN H. E. and REINHARD J. F. JR. (1996): The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirol., 2, 111-117.
65. NOTTET H. S. L. M., JETT M., FLANAGAN C. R., ZHAI Q. H., PERSIDSKY Y., RIZZINO A., BERNTON E. W., GENIS P., BALDWIN T., SCHWARTZ J. et al. (1995): A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol., 154, 3567-3581.
66. NOTTET H. S. L. M., PERSIDSKY Y., SASSEVILLE V. G., NUKUNA A. N., BOCK P., ZHAI Q. H., SHARER L. R., MCCOMB R. D., SWINDELLS S., SODERLAND C. and GENDELMAN H. E. (1996): Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol., 156, 1284-1295.
67. PECHAN P. A., CHOWDHURY K. and SEIFERT W. (1992): Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. Neuroreport, 3, 469-472.
68. PERRY S. W., HAMILTON J. A., TJOELKER L. W., DBAIBO G., DZENKO K. A., EPSTEIN L. G., HANNUN Y., WHITTAKER J. S., DEWHURST S. and GELBARD H. A. (1998): Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J. Biol. Chem., 273, 17660-17664.
69. PETERSON P. K., HU S., SALAK JOHNSON J., MOLITOR T. W. and CHAO C. C. (1997): Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J. Infect. Dis., 175, 478-481.
70. PRESCOTT S. M., ZIMMERMAN G. A. and MCINTYRE T. M. (1990): Platelet-activating factor. J. Biol. Chem., 268, 17381-17384.
71. PRICE R. W., BREW B., SIDTIS J., ROSENBLUM M., SCHECK A. C. and CLEARY P. (1988): The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 239, 586-592.
72. PROOST P., WUYTS A. and VAN DAMME J. (1996): The role of chemokines in inflammation. Int. J. Clin. Lab. Res., 26, 211-223.
73. RANDOLPH G. J. and FURIE M. B. (1995): A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J. Immunol., 155, 3610-3618.
74. RANKI A., NYBERG M., OVOD V., HALTIA M., ELOVAARA I., RAININKO R., HAAPASALO H. and KROHN K. (1995): Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS, 9, 1001-1008.
75. RUBARTELLI A., POGGI A., SITIA R. and ZOCCHI M. R. (1998): HIV-1 tat: a polypeptide for all seasons. Immunol. Today, 19, 543-545.
76. SABATIER J. M., VIVES E., MABROUK K., BENJOUAD A., ROCHAT H., DUVAL A., HUE B. and BAHRAOUI E. (1991): Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol., 65, 961-967.
77. SCHMIDTMAYEROVA H., NOTTET H. S. L. M., NUOVO G., RAABE T., FLANAGAN C. R., DUBROVSKY L., GENDELMAN H. E., CERAMI A., BUKRINSKY M. and SHERRY B. (1996): Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA, 93, 700-704.
78. SHRIKANT P., BENOS D. J., TANG L. P. and BENVENISTE E. N. (1996): HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol., 156, 1307-1314.
79. SOONTORNNIYOMKIJ V., WANG G., PITTMAN C. A., WILEY C. A. and ACHIM C. (1998): Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type I encephalitis. Neuropathol. Appl. Neurobiol., 24, 453-460.
80. SPORER B., PAUL R., KOEDEL U., GRIMM R., WICK M., GOEBEL F. D. and PFISTER H. W. (1998): Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J. Infect. Dis., 178, 854-857.
81. STUART R. O. and NIGAM S. K. (1995): Regulated assembly of tight junctions by protein kinase C. Proc. Natl. Acad. Sci. USA, 92, 6072-6076.
82. TYLOR W. R., GLASS J. D., GRIFFIN J. W., BECKER P. S., MC ARTHUR J. C., BEZMAN L. and GRIFFIN D. E. (1992): Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol., 31, 349-360.
83. UGUCCIONI M., D'APUZZO M., LOETSCHER M., DEWALD B. and BAGGIOLINI M. (1995): Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur. J. Immunol., 25, 64-68.
84. VAISHNAV Y. N and WONG STAAL F. (1991): The biochemistry of AIDS. Annu. Rev. Biochem., 60, 578-630.
85. VINCENT V. A., DE GROOT C. J., LUCASSEN P. J. PORTEGIES P., TROOST D., TILDERS F. J. and VAN DAM A. M. (1999): Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. AIDS, 13, 317-326.
86. YEUNG M. C., PULLIAM L. and LAU A. S. (1995): The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS, 9, 137-143.
87. YONG V. W., KREKOSKI C. A., FORSYTH P. A., BELL R. and EDWARDS D. R. (1998): Matrix metalloproteinases and diseases of the CNS. Trends Neurosci., 21, 75-80.
88. WEMPE F., LINDNER V. and AUGUSTIN H. G. (1997): Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MPC-1) in autocrine-activated endothelial cells. Arterioscler. Thromb. Vase. Biol., 17, 2471-2478.
89. WESSELINGH S. L., POWER C., GLASS J. D., TYOR W. R., MC ARTHUR J. C., FARBER J. M., GRIFFIN J. W. and GRIFFIN D. E. (1993): Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol., 33, 576-582.
90. WILEY C. A. and ACHIM C. (1994): Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol., 36, 673-676.
91. WILEY C. A., SCHRIER R. D., NELSON J. A., LAMPERT P. W. and OLDSTONE M. B. (1986): Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA, 83, 7089-7093.
92. WYSS CORAY T., MASLIAH E., TOGGAS S. M., ROCKENSTEIN E. M., BROOKER M. J., LEE H. S. and MUCKE L. (1996): Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest., 97, 789-798.